ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.053 AUD -1.85% Market Closed
Market Cap: 107.2m AUD
Have any thoughts about
ImpediMed Ltd?
Write Note

ImpediMed Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ImpediMed Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
R
RSH
C
CYC
COH
OIL
EMV

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Cash & Cash Equivalents
AU$24.6m
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
9%
R
Respiri Ltd
ASX:RSH
Cash & Cash Equivalents
AU$762.9k
CAGR 3-Years
-54%
CAGR 5-Years
20%
CAGR 10-Years
-21%
C
Cyclopharm Ltd
ASX:CYC
Cash & Cash Equivalents
AU$27.6m
CAGR 3-Years
-5%
CAGR 5-Years
37%
CAGR 10-Years
35%
Cochlear Ltd
ASX:COH
Cash & Cash Equivalents
AU$513.6m
CAGR 3-Years
-6%
CAGR 5-Years
46%
CAGR 10-Years
25%
Optiscan Imaging Ltd
ASX:OIL
Cash & Cash Equivalents
AU$6.1m
CAGR 3-Years
-10%
CAGR 5-Years
28%
CAGR 10-Years
56%
EMvision Medical Devices Ltd
ASX:EMV
Cash & Cash Equivalents
AU$18.6m
CAGR 3-Years
24%
CAGR 5-Years
34%
CAGR 10-Years
N/A

See Also

What is ImpediMed Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
24.6m AUD

Based on the financial report for Jun 30, 2024, ImpediMed Ltd's Cash & Cash Equivalents amounts to 24.6m AUD.

What is ImpediMed Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
9%

Over the last year, the Cash & Cash Equivalents growth was -46%. The average annual Cash & Cash Equivalents growth rates for ImpediMed Ltd have been 8% over the past three years , 17% over the past five years , and 9% over the past ten years .

Back to Top